383 related articles for article (PubMed ID: 24072004)
1. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
Flint AC; Faigeles BS; Cullen SP; Kamel H; Rao VA; Gupta R; Smith WS; Bath PM; Donnan GA;
Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
[TBL] [Abstract][Full Text] [Related]
2. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
3. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
[TBL] [Abstract][Full Text] [Related]
4. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
[TBL] [Abstract][Full Text] [Related]
5. THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial.
Flint AC; Xiang B; Gupta R; Nogueira RG; Lutsep HL; Jovin TG; Albers GW; Liebeskind DS; Sanossian N; Smith WS;
Stroke; 2013 Dec; 44(12):3370-5. PubMed ID: 24072003
[TBL] [Abstract][Full Text] [Related]
6. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
7. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
[TBL] [Abstract][Full Text] [Related]
8. Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation.
Flint AC; Rao VA; Chan SL; Cullen SP; Faigeles BS; Smith WS; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Johnston SC;
Int J Stroke; 2015 Aug; 10(6):815-21. PubMed ID: 26045081
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
10. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
[TBL] [Abstract][Full Text] [Related]
12. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage.
Gumbinger C; Gruschka P; Böttinger M; Heerlein K; Barrows R; Hacke W; Ringleb P
Stroke; 2012 Jan; 43(1):240-2. PubMed ID: 21998049
[TBL] [Abstract][Full Text] [Related]
13. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
[TBL] [Abstract][Full Text] [Related]
14. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
15. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
[TBL] [Abstract][Full Text] [Related]
16. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
[TBL] [Abstract][Full Text] [Related]
17. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
[TBL] [Abstract][Full Text] [Related]
18. Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.
Mazya MV; Ahmed N; Ford GA; Hobohm C; Mikulik R; Nunes AP; Wahlgren N;
Stroke; 2014 Jun; 45(6):1657-63. PubMed ID: 24788971
[TBL] [Abstract][Full Text] [Related]
19. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
20. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
Al-Khaled M; Matthis C; Eggers J
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
